topmenu
Wyniki wyszukiwania:
wyszukanych pozycji: 9
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9781461469155 / Angielski / Twarda / 2013 / 338 str. Termin realizacji zamówienia: ok. 22 dni roboczych. In its new edition, this book reviews the challenges facing quality assurance and control (QA/QC) in today's biopharmaceutical environment, putting into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.
In its new edition, this book reviews the challenges facing quality assurance and control (QA/QC) in today's biopharmaceutical environment, putting in...
|
cena:
1006,38 |
 |
Family Trip To Magical Madagascar And Beyond
ISBN: 9781950947751 / Angielski / Miękka / 2019 / 68 str. Termin realizacji zamówienia: ok. 16-18 dni roboczych. |
cena:
57,51 |
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9781493943999 / Angielski / Miękka / 2016 / 338 str. Termin realizacji zamówienia: ok. 22 dni roboczych. In its new edition, this book reviews the challenges facing quality assurance and control (QA/QC) in today's biopharmaceutical environment, putting into perspective the need for a graded approach to QA/QC from early clinical trials through market approval.
In its new edition, this book reviews the challenges facing quality assurance and control (QA/QC) in today's biopharmaceutical environment, putting in...
|
cena:
724,58 |
 |
Who's Yawning Now?
ISBN: 9781951775834 / Angielski / Miękka / 2020 / 42 str. Termin realizacji zamówienia: ok. 16-18 dni roboczych. |
cena:
57,02 |
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9783031319112 / Angielski / Miękka / 2024 Termin realizacji zamówienia: ok. 22 dni roboczych. Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion proteins, and Fab fragments are now in the marketplace in both the United States of America (USA) and European Union (EU). There are also now over 60 biosimilars available for all major classes of recombinant proteins and monoclonal antibodies. In addition, gene therapies using genetically engineered...
Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), o...
|
cena:
563,56 |
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9781461348047 / Angielski / Miękka / 2012 / 350 str. Termin realizacji zamówienia: ok. 22 dni roboczych. "The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that would rapidly become out of date. My primary purpose was to provide insight and practical suggestions into a common sense business approach to manage the CMC regulatory compliance requirements for biopharmaceuticals. Such a common sense business approach would need (1) to be applicable for all types...
"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 M...
|
cena:
805,10 |
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9783030137533 / Angielski / Twarda / 2019 / 426 str. Termin realizacji zamówienia: ok. 22 dni roboczych. |
cena:
644,07 |
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9783031319082 / Angielski Termin realizacji zamówienia: ok. 22 dni roboczych. Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion proteins, and Fab fragments are now in the marketplace in both the United States of America (USA) and European Union (EU). There are also now over 60 biosimilars available for all major classes of recombinant proteins and monoclonal antibodies. In addition, gene therapies using genetically engineered...
Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food & Drug Administration (FDA), o...
|
cena:
805,10 |
 |
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
ISBN: 9780306480409 / Angielski / Twarda / 2003 / 350 str. Termin realizacji zamówienia: ok. 22 dni roboczych. "The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 My primary purpose for writing this book was much more than to provide another information source on Chemistry, Manufacturing & Controls (CMC) that would rapidly become out of date. My primary purpose was to provide insight and practical suggestions into a common sense business approach to manage the CMC regulatory compliance requirements for biopharmaceuticals. Such a common sense business approach would need (1) to be applicable for all types...
"The greater our knowledge increases, the more our ignorance unfolds. " U. S. President John F. Kennedy, speech, Rice University, September 12, 1962 M...
|
cena:
805,10 |
Czytaj nas na:
Zobacz: Księgarnia Czeska | Wydawnictwo Książkowe Klimaty | Mapa strony | Lista autorów
KrainaKsiazek.PL - Księgarnia Internetowa
KrainaKsiazek.PL - Księgarnia Internetowa
